| Health / Medical Topics |
Monoclonal Antibody HuMV833
A humanized monoclonal antibody directed against vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. HuMV833 has been shown to decrease the permeability of blood vessels that supply tumors, an effect which may lead to slowed tumor growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on…
A humanized monoclonal antibody (MoAb) against the external domain of the Prostate-specific membrane antigen (PSMA), overexpressed in the malignant prostate and its…
A humanized monoclonal antibody directed against MUC1, a mucin glycoprotein overexpressed in breast and other carcinomas. Monoclonal antibody HuHMFG1 stimulates antibody-dependent…
A humanized monoclonal antibody directed against alpha fetoprotein with potential antineoplastic activity. Upon administration, monoclonal antibody HuAFP31 (mAb HuAFP31) binds to and…
A humanized monoclonal antibody directed against the Lewis Y antigen, a tumor-associated epithelial antigen, with potential antineoplastic activity. Following binding, monoclonal antibody…
A recombinant monoclonal antibody directed against the human suppressor-cytotoxic T-cell subset and designed to deplete circulating Leu 2A-positive lymphocytes. The antigen…
